RET Fusions Define a Unique Molecular and Clinicopathologic Subtype of Non–Small-Cell Lung Cancer
The RET fusion gene has been recently described in a subset of non-small-cell lung cancers (NSCLCs). Because we have limited knowledge about these tumors, this study was aimed at determining the clinicopathologic characteristics of patients with NSCLC harboring the RET fusion gene. We examined the R...
Saved in:
Published in | Journal of clinical oncology Vol. 30; no. 35; pp. 4352 - 4359 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Alexandria, VA
American Society of Clinical Oncology
10.12.2012
|
Subjects | |
Online Access | Get full text |
ISSN | 0732-183X 1527-7755 1527-7755 |
DOI | 10.1200/JCO.2012.44.1477 |
Cover
Loading…